🇺🇸 FDA
Pipeline program

BIIB111

NSR-CHM-OS2 273CH201

Phase 3 small_molecule active

Quick answer

BIIB111 for Choroideremia (CHM) X-Linked Retinitis Pigmentosa (XLRP) is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Biogen Idec Ltd
Indication
Choroideremia (CHM) X-Linked Retinitis Pigmentosa (XLRP)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials